Probiotic interventions promote metabolic health in high fat-fed hamsters in association with gut microbiota and endocannabinoidome alterations
In: Beneficial MicrobesCentre de recherche de l’Institut universitaire de cardiologie et de pneumologie de Québec (IUCPQ), 2725 Ch Ste-Foy, Québec City, Quebec G1V 4G5, Canada.
Canada Research Excellence Chair in the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Université Laval, Québec, Canada.
Search for other papers by S. Lacroix in
Current site
Google Scholar
Canada Research Excellence Chair in the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Université Laval, Québec, Canada.
École de nutrition, Faculté des sciences de l’agriculture et de l’alimentation (FSAA), Université Laval, 2425 Rue de l’Agriculture, Québec City, Quebec G1V 0A6, Canada.
Search for other papers by N. Leblanc in
Current site
Google Scholar
Canada Research Excellence Chair in the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Université Laval, Québec, Canada.
Search for other papers by A. Abolghasemi in
Current site
Google Scholar
Search for other papers by S. Paris-Robidas in
Current site
Google Scholar
Canada Research Excellence Chair in the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Université Laval, Québec, Canada.
Search for other papers by C. Martin in
Current site
Google Scholar
Search for other papers by M. Frappier in
Current site
Google Scholar
Canada Research Excellence Chair in the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Université Laval, Québec, Canada.
Département de médecine, Faculté de Médecine, Université Laval, 1050 Av. de la Médecine, Québec City, Quebec G1V 0A6, Canada.
Search for other papers by N. Flamand in
Current site
Google Scholar
Canada Research Excellence Chair in the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Université Laval, Québec, Canada.
Département de médecine, Faculté de Médecine, Université Laval, 1050 Av. de la Médecine, Québec City, Quebec G1V 0A6, Canada.
Search for other papers by C. Silvestri in
Current site
Google Scholar
Canada Research Excellence Chair in the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Université Laval, Québec, Canada.
École de nutrition, Faculté des sciences de l’agriculture et de l’alimentation (FSAA), Université Laval, 2425 Rue de l’Agriculture, Québec City, Quebec G1V 0A6, Canada.
Search for other papers by F. Raymond in
Current site
Google Scholar
Search for other papers by M. Millette in
Current site
Google Scholar
Centre de recherche de l’Institut universitaire de cardiologie et de pneumologie de Québec (IUCPQ), 2725 Ch Ste-Foy, Québec City, Quebec G1V 4G5, Canada.
Canada Research Excellence Chair in the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Université Laval, Québec, Canada.
École de nutrition, Faculté des sciences de l’agriculture et de l’alimentation (FSAA), Université Laval, 2425 Rue de l’Agriculture, Québec City, Quebec G1V 0A6, Canada.
Département de médecine, Faculté de Médecine, Université Laval, 1050 Av. de la Médecine, Québec City, Quebec G1V 0A6, Canada.
Joint International Unit between the National Research Council (CNR) of Italy and Université Laval on Chemical and Biomolecular Research on the Microbiome and its Impact on Metabolic Health and Nutrition (UMI-MicroMeNu), Institute of Biomolecular Chemistry, CNR, Pozzuoli, Italy.
Search for other papers by V. Di Marzo in
Current site
Google Scholar
Centre de recherche de l’Institut universitaire de cardiologie et de pneumologie de Québec (IUCPQ), 2725 Ch Ste-Foy, Québec City, Quebec G1V 4G5, Canada.
Canada Research Excellence Chair in the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Université Laval, Québec, Canada.
École de nutrition, Faculté des sciences de l’agriculture et de l’alimentation (FSAA), Université Laval, 2425 Rue de l’Agriculture, Québec City, Quebec G1V 0A6, Canada.
Search for other papers by A. Veilleux in
Current site
Google Scholar
Probiotics represent a promising tool to improve metabolic health, including lipid profiles and cholesterol levels. Modulation of the gut microbiome and the endocannabinoidome – two interrelated systems involved in several metabolic processes influenced by probiotics – has been proposed as a potential mechanism of action. This study establishes the impact of probiotics on metabolic health, gut microbiota composition and endocannabinoidome mediators in an animal model of hypercholesterolaemia. Syrian hamsters were fed either a low-fat low-cholesterol or high-fat high-cholesterol (HFHC) diet to induce hypercholesterolaemia and gavaged for 6 weeks with either Lactobacillus acidophilus CL1285, Lactiplantibacillus plantarum CHOL-200 or a combination of the two. Globally, probiotic interventions ameliorated, at least partially, lipid metabolism in HFHC-fed hamsters. The interventions, especially those including L. acidophilus, modified the gut microbiota composition of the small intestine and caecum in ways suggesting reversal of HFHC-induced dysbiosis. Several associations were observed between changes in gut microbiota composition and endocannabinoidome mediators following probiotic interventions and both systems were also associated with improved metabolic health parameters. For instance, potential connexions between the Eubacteriaceae and Deferribacteraceae families, levels of 2‑palmitoylglycerol, 2‑oleoylglycerol, 2‑linoleoylglycerol or 2‑eicosapentaenoylglycerol and improved lipid profiles were found. Altogether, our results suggest a potential crosstalk between gut microbiota and the endocannabinoidome in driving metabolic benefits associated with probiotics, especially those including L. acidophilus, in an animal model of hypercholesterolaemia.
Purchase
Buy instant access (PDF download and unlimited online access):
Institutional Login
Log in with Open Athens, Shibboleth, or your institutional credentials
Personal login
Log in with your brill.com account
-
Avraham, Y., Katzhendler, J., Vorobeiv, L., Merchavia, S., Listman, C., Kunkes, E., Harfoush, F., Salameh, S., Ezra, A.F., Grigoriadis, N.C., Berry, E.M. and Najajreh, Y., 2013. Novel acylethanolamide derivatives that modulate body weight through enhancement of hypothalamic pro-opiomelanocortin (POMC) and/or decreased neuropeptide y (NPY). Journal of Medicinal Chemistry 56: 1811-1829. https://doi.org/10.1021/jm300484d
-
Bhaskaragoud, G., Rajath, S., Mahendra, V.P., Kumar, G.S., Gopala Krishna, A.G. and Kumar, G.S., 2016. Hypolipidemic mechanism of oryzanol components – ferulic acid and phytosterols. Biochemical and Biophysical Research Communications 476: 82-89. https://doi.org/10.1016/j.bbrc.2016.05.053
-
Callahan, B.J., McMurdie, P.J., Rosen, M.J., Han, A.W., Johnson, A.J.A. and Holmes, S.P., 2016. DADA2: High-resolution sample inference from Illumina amplicon data. Nature Methods 13: 581-583. https://doi.org/10.1038/nmeth.3869
-
Cani, P. D., Plovier, H., Hul, M. Van, Geurts, L., Delzenne, N.M., Druart, C. and Everard, A., 2016. Endocannabinoids – at the crossroads between the gut microbiota and host metabolism. Nature Reviews Endocrinology 12: 133-143.
'Endocannabinoids – at the crossroads between the gut microbiota and host metabolism ' () 12 Nature Reviews Endocrinology : 133 -143.
-
Castonguay-Paradis, S., Lacroix, S., Rochefort, G., Parent, L., Perron, J., Martin, C., Lamarche, B., Raymond, F., Flamand, N., Di Marzo, V. and Veilleux, A., 2020. Dietary fatty acid intake and gut microbiota determine circulating endocannabinoidome signaling beyond the effect of body fat. Scientific Reports 10: 15975. https://doi.org/10.1038/s41598-020-72861-3
-
Companys, J., Pla-Pagà, L., Calderón-Pérez, L., Llauradó, E., Solà, R., Pedret, A. and Valls, R.M., 2020. Fermented dairy products, probiotic supplementation, and cardiometabolic diseases: a systematic review and meta-analysis. Advances in Nutrition 11: 834-863. https://doi.org/10.1093/advances/nmaa030.
-
Costabile, A., Buttarazzi, I., Kolida, S., Quercia, S., Baldini, J., Swann, J.R., Brigidi, P. and Gibson, G.R., 2017. An in vivo assessment of the cholesterol-lowering efficacy of Lactobacillus plantarum ECGC 13110402 in normal to mildly hypercholesterolaemic adults. PLoS ONE 12: e0187964. https://doi.org/10.1371/journal.pone.0187964
-
Den Besten, G., Van Eunen, K., Groen, A.K., Venema, K., Reijngoud, D.J. and Bakker, B.M., 2013. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. Journal of Lipid Research 54: 2325-2340. https://doi.org/10.1194/jlr.R036012
-
Di Marzo, V., 2018. New approaches and challenges to targeting the endocannabinoid system. Nature Reviews Drug Discovery 17: 623-639. https://doi.org/10.1038/nrd.2018.115
-
Di Marzo, V. and Silvestri, C., 2019. Lifestyle and metabolic syndrome: Contribution of the endocannabinoidome. Nutrients 11: 1956. https://doi.org/10.3390/nu11081956
-
Dione, N., Lacroix, S., Taschler, U., Deschênes, T., Abolghasemi, A., Leblanc, N., Di Marzo, V. and Silvestri, C., 2020. Mgll knockout mouse resistance to diet-induced dysmetabolism is associated with altered gut microbiota. Cells 9: 2705. https://doi.org/10.3390/cells9122705
-
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J.P., Druart, C., Bindels, L.B., Guiot, Y., Derrien, M., Muccioli, G.G., Delzenne, N.M., Vos, W.M. de and Cani, P.D., 2013. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proceedings of the National Academy of Sciences of the USA 110: 9066-9071. https://doi.org/10.1073/pnas.1219451110
-
Everard, A., Plovier, H., Rastelli, M., Van Hul, M., de Wouters d’Oplinter, A., Geurts, L., Druart, C., Robine, S., Delzenne, N.M., Muccioli, G.G., de Vos, W.M., Luquet, S., Flamand, N., Di Marzo, V. and Cani, P.D., 2019. Intestinal epithelial N-acylphosphatidylethanolamine phospholipase D links dietary fat to metabolic adaptations in obesity and steatosis. Nature Communications 10: 457. https://doi.org/10.1038/s41467-018-08051-7
-
Fornelos, N., Franzosa, E.A., Bishai, J., Annand, J.W., Oka, A., Lloyd-Price, J., Arthur, T.D., Garner, A., Avila-Pacheco, J., Haiser, H.J., Tolonen, A.C., Porter, J.A., Clish, C.B., Sartor, R.B., Huttenhower, C., Vlamakis, H. and Xavier, R.J., 2020. Growth effects of N-acylethanolamines on gut bacteria reflect altered bacterial abundances in inflammatory bowel disease. Nature Microbiology 5: 486-497. https://doi.org/10.1038/s41564-019-0655-7
-
Frappier, M., Auclair, J., Bouasker, S., Gunaratnam, S., Diarra, C. and Millette, M., 2022. Screening and characterization of some Lactobacillaceae for detection of cholesterol-lowering activities. Probiotics and Antimicrobial Proteins 14, 873-883https://doi.org/10.1007/s12602-022-09959-9
-
Goderska, K., Agudo Pena, S. and Alarcon, T., 2018. Helicobacter pylori treatment: antibiotics or probiotics. Applied Microbiology and Biotechnology 102: 1-7. https://doi.org/10.1007/s00253-017-8535-7
-
Guo, C.-F., Zhang, S., Yuan, Y.-H., Li, J.-Y. and Yue, T.-L., 2018. Bile salt hydrolase and s-layer protein are the key factors affecting the hypocholesterolemic activity of Lactobacillus casei-fermented milk in hamsters. Molecular Nutrition and Food Research 62: e1800728. https://doi.org/10.1002/mnfr.201800728
-
Gustafsson, B.E., Angelin, B., Einarsson, K. and Gustafsson, J.A., 1978. Influence of cholestyramine on synthesis of cholesterol and bile acids in germfree rats. Journal of Lipid Research 19: 972-977.
'Influence of cholestyramine on synthesis of cholesterol and bile acids in germfree rats ' () 19 Journal of Lipid Research : 972 -977.
-
Hemarajata, P. and Versalovic, J., 2013. Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Therapeutic Advances in Gastroenterology 6: 39-51. https://doi.org/10.1177/1756283X12459294
-
Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., Morelli, L., Canani, R.B., Flint, H.J., Salminen, S., Calder, P.C. and Sanders, M.E., 2014. Expert consensus document: The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology and Hepatology 11: 506-514. https://doi.org/10.1038/nrgastro.2014.66
-
Homan, M. and Orel, R., 2015. Are probiotics useful in Helicobacter pylori eradication? World Journal of Gastroenterology 21: 10644. https://doi.org/10.3748/wjg.v21.i37.10644
-
Hu, Y.W., Yang, J.Y., Ma, X., Chen, Z.P., Hu, Y.R., Zhao, J.Y., Li, S.F., Qiu, Y.R., Lu, J.B., Wang, Y.C., Gao, J.J., Sha, Y.H., Zheng, L. and Wang, Q., 2014. A lincRNA-DYNLRB2-2/GPR119/GLP-1R/ABCA1-dependent signal transduction pathway is essential for the regulation of cholesterol homeostasis. Journal of Lipid Research 55: 681-697. https://doi.org/10.1194/jlr.M044669
-
Kaakoush, N. O., 2015. Insights into the role of Erysipelotrichaceae in the human host. Frontiers in Cellular and Infection Microbiology:5: 84. https://doi.org/10.3389/fcimb.2015.00084
-
Kim, J., Carlson, M.E., Kuchel, G.A., Newman, J.W. and Watkins, B.A., 2016. Dietary DHA reduces downstream endocannabinoid and inflammatory gene expression and epididymal fat mass while improving aspects of glucose use in muscle in C57BL/6J mice. International Journal of Obesity 40: 129-137. https://doi.org/10.1038/ijo.2015.135
-
Kuipers, E.N., Kantae, V., Maarse, B.C.E., van den Berg, S.M., van Eenige, R., Nahon, K.J., Reifel-Miller, A., Coskun, T., de Winther, M.P.J., Lutgens, E., Kooijman, S., Harms, A.C., Hankemeier, T., van der Stelt, M., Rensen, P.C.N. and Boon, M.R., 2019. High fat diet increases circulating endocannabinoids accompanied by increased synthesis enzymes in adipose tissue. Frontiers in Physiology 9: 1913. https://doi.org/10.3389/fphys.2018.01913
-
Lacroix, S., Pechereau, F., Leblanc, N., Boubertakh, B., Houde, A., Martin, C., Flamand, N., Silvestri, C., Raymond, F., Di Marzo, V. and Veilleux, A., 2019. Rapid and concomitant gut microbiota and endocannabinoidome response to diet-induced obesity in mice. mSystems 4: e00407-19. https://doi.org/10.1128/msystems.00407-19
-
Laleh, P., Yaser, K. and Alireza, O., 2019. Oleoylethanolamide: a novel pharmaceutical agent in the management of obesity-an updated review. Journal of Cellular Physiology 234: 7893-7902. https://doi.org/10.1002/jcp.27913
-
Lê, S., Josse, J. and Husson, F., 2008. FactoMineR: An R package for multivariate analysis. Journal of Statistical Software 25: 1-18. https://doi.org/10.18637/jss.v025.i01
-
Magne, F., Gotteland, M., Gauthier, L., Zazueta, A., Pesoa, S., Navarrete, P. and Balamurugan, R., 2020. The Firmicutes/Bacteroidetes ratio: a relevant marker of gut dysbiosis in obese patients? Nutrients 12: 1474. https://doi.org/10.3390/nu12051474
-
Manca, C., Boubertakh, B., Leblanc, N., Deschênes, T., Lacroix, S., Martin, C., Houde, A., Veilleux, A., Flamand, N., Muccioli, G. G., Raymond, F., Cani, P. D., Di Marzo, V. and Silvestri, C., 2020. Germfree mice exhibit profound gut microbiota-dependent alterations of intestinal endocannabinoidome signaling. Journal of Lipid Research 61: 70-85. https://doi.org/10.1194/jlr.RA119000424
-
Mard, S.A., Haghighian, H.K., Sebghatulahi, V. and Ahmadi, B., 2014. Dietary factors in relation to Helicobacter pylori infection. Gastroenterology Research and Practice 2014: 826910. https://doi.org/10.1155/2014/826910
-
McMurdie, P.J. and Holmes, S., 2012. Phyloseq: A bioconductor package for handling and analysis of high-throughput phylogenetic sequence data. Pacific Symposium on Biocomputing. 235-246. https://doi.org/10.1142/9789814366496_0023
-
Muccioli, G.G., Naslain, D., Bäckhed, F., Reigstad, C.S., Lambert, D.M., Delzenne, N.M. and Cani, P.D., 2010. The endocannabinoid system links gut microbiota to adipogenesis. Molecular Systems Biology 6: 392. https://doi.org/10.1038/msb.2010.46
-
Naughton, S.S., Mathai, M.L., Hryciw, D.H. and McAinch, A.J., 2013. Fatty acid modulation of the endocannabinoid system and the effect on food intake and metabolism. International Journal of Endocrinology 2013: 361895. https://doi.org/10.1155/2013/361895
-
Nunez, D.J., Bush, M.A., Collins, D.A., McMullen, S.L., Gillmor, D., Apseloff, G., Atiee, G., Corsino, L., Morrow, L. and Feldman, P.L., 2014. Gut hormone pharmacology of a novel GPR119 agonist (GSK1292263), metformin, and sitagliptin in type 2 diabetes mellitus: results from two randomized studies. PLoS ONE 9: e92494. https://doi.org/10.1371/journal.pone.0092494
-
Oksanen, J., Blanchet, F.G., Friendly, M., Kindt, R., Legendre, P., McGlinn, D., Minchin, P.R., O’Hara, R.B., Simpson, G. L., Solymos, P., Stevens, M.H.H., Szoecs, E. and Wagner, H., 2019. vegan: Community Ecology Package. R package version 2.5-2. Cran R.
'vegan: Community Ecology Package', ().
-
Paradis, E. and Schliep, K., 2019. ape 5.0: an environment for modern phylogenetics and evolutionary analyses in R. Bioinformatics 35: 526-528
'ape 5.0: an environment for modern phylogenetics and evolutionary analyses in R ' () 35 Bioinformatics : 526 -528.
-
Paulson, J.N., Talukder, H., Pop, M. and Bravo, H.C., 2013. Robust methods for differential abundance analysis in marker gene surveys. Nature Methods 10: 1200-1202. https://doi.org/10.1016/j.biotechadv.2011.08.021
-
Pellizzon, M.A. and Ricci, M.R., 2018. The common use of improper control diets in diet-induced metabolic disease research confounds data interpretation: the fiber factor. Nutrition and Metabolism 15: 3. https://doi.org/10.1186/s12986-018-0243-5
-
Qiao, Y., Sun, J., Xie, Z., Shi, Y. and Le, G., 2014. Propensity to high-fat diet-induced obesity in mice is associated with the indigenous opportunistic bacteria on the interior of Peyer’s patches. Journal of Clinical Biochemistry and Nutrition 55: 120-128. https://doi.org/10.3164/jcbn.14-38
-
Ru, X., Zhang, C.C., Yuan, Y.H., Yue, T.L. and Guo, C.F., 2019. Bile salt hydrolase activity is present in nonintestinal lactic acid bacteria at an intermediate level. Applied Microbiology and Biotechnology 103: 893-902. https://doi.org/10.1007/s00253-018-9492-5
-
Russo, M., Marquez, A., Abeijón-Mukdsi, M.C., Santacruz, A., López-Malo, A., Gauffin-Cano, P. and Medina, R., 2019. Microencapsulated feruloyl esterase-producing lactobacilli ameliorate lipid profile and glycaemia in high fat diet-induced obese mice. Beneficial Microbes 10: 189-198.
'Microencapsulated feruloyl esterase-producing lactobacilli ameliorate lipid profile and glycaemia in high fat diet-induced obese mice ' () 10 Beneficial Microbes : 189 -198.
-
Russo, M., Marquez, A., Herrera, H., Abeijon-Mukdsi, C., Saavedra, L., Hebert, E., Gauffin-Cano, P. and Medina, R., 2020. Oral administration of Lactobacillus fermentum CRL1446 improves biomarkers of metabolic syndrome in mice fed a high-fat diet supplemented with wheat bran. Food Function 11: 3879-3894. https://doi.org/10.1039/d0fo00730g
-
Sánchez, B., Delgado, S., Blanco-Míguez, A., Lourenço, A., Gueimonde, M. and Margolles, A., 2017. Probiotics, gut microbiota, and their influence on host health and disease. Molecular Nutrition and Food Research61, 1600240. https://doi.org/10.1002/mnfr.201600240
-
Sarao, L.K. and Arora, M., 2017. Probiotics, prebiotics, and microencapsulation: a review. Critical Reviews in Food Science and Nutrition 57: 344-371. https://doi.org/10.1080/10408398.2014.887055
-
Wilkins, L.J., Monga, M. and Miller, A.W., 2019. Defining dysbiosis for a cluster of chronic diseases. Scientific Reports 9: 12918. https://doi.org/10.1038/s41598-019-49452-y
-
Xia, Y., Meng, G., Zhang, Q., Liu, L., Wu, H., Shi, H., Bao, X., Su, Q., Gu, Y., Fang, L., Yu, F., Yang, H., Yu, B., Sun, S., Wang, X., Zhou, M., Jia, Q., Zhao, H., Song, K. and Niu, K., 2016. Dietary patterns are associated with helicobacter pylori infection in Chinese adults: a cross-sectional study. Scientific Reports 6: 32334. https://doi.org/10.1038/srep32334
-
Yang, J.W., Kim, H.S., Choi, Y.W., Kim, Y.M. and Kang, K.W., 2018. Therapeutic application of GPR119 ligands in metabolic disorders. Diabetes, Obesity and Metabolism. 20: 257-269. https://doi.org/10.1111/dom.13062
-
Yang, J.W., Kim, H.S., Im, J.H., Kim, J.W., Jun, D.W., Lim, S.C., Lee, K., Choi, J.M., Kim, S.K. and Kang, K.W., 2016. GPR119: A promising target for nonalcoholic fatty liver disease. FASEB Journal 30: 324-335. https://doi.org/10.1096/fj.15-273771
Supplementary Materials
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 863 | 204 | 33 |
| Full Text Views | 52 | 6 | 0 |
| PDF Views & Downloads | 71 | 15 | 0 |
Probiotic interventions promote metabolic health in high fat-fed hamsters in association with gut microbiota and endocannabinoidome alterations
In: Beneficial MicrobesCentre de recherche de l’Institut universitaire de cardiologie et de pneumologie de Québec (IUCPQ), 2725 Ch Ste-Foy, Québec City, Quebec G1V 4G5, Canada.
Canada Research Excellence Chair in the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Université Laval, Québec, Canada.
Search for other papers by S. Lacroix in
Current site
Google Scholar
PubMed
Canada Research Excellence Chair in the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Université Laval, Québec, Canada.
École de nutrition, Faculté des sciences de l’agriculture et de l’alimentation (FSAA), Université Laval, 2425 Rue de l’Agriculture, Québec City, Quebec G1V 0A6, Canada.
Search for other papers by N. Leblanc in
Current site
Google Scholar
PubMed
Canada Research Excellence Chair in the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Université Laval, Québec, Canada.
Search for other papers by A. Abolghasemi in
Current site
Google Scholar
PubMed
Search for other papers by S. Paris-Robidas in
Current site
Google Scholar
PubMed
Canada Research Excellence Chair in the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Université Laval, Québec, Canada.
Search for other papers by C. Martin in
Current site
Google Scholar
PubMed
Search for other papers by M. Frappier in
Current site
Google Scholar
PubMed
Canada Research Excellence Chair in the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Université Laval, Québec, Canada.
Département de médecine, Faculté de Médecine, Université Laval, 1050 Av. de la Médecine, Québec City, Quebec G1V 0A6, Canada.
Search for other papers by N. Flamand in
Current site
Google Scholar
PubMed
Canada Research Excellence Chair in the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Université Laval, Québec, Canada.
Département de médecine, Faculté de Médecine, Université Laval, 1050 Av. de la Médecine, Québec City, Quebec G1V 0A6, Canada.
Search for other papers by C. Silvestri in
Current site
Google Scholar
PubMed
Canada Research Excellence Chair in the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Université Laval, Québec, Canada.
École de nutrition, Faculté des sciences de l’agriculture et de l’alimentation (FSAA), Université Laval, 2425 Rue de l’Agriculture, Québec City, Quebec G1V 0A6, Canada.
Search for other papers by F. Raymond in
Current site
Google Scholar
PubMed
Search for other papers by M. Millette in
Current site
Google Scholar
PubMed
Centre de recherche de l’Institut universitaire de cardiologie et de pneumologie de Québec (IUCPQ), 2725 Ch Ste-Foy, Québec City, Quebec G1V 4G5, Canada.
Canada Research Excellence Chair in the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Université Laval, Québec, Canada.
École de nutrition, Faculté des sciences de l’agriculture et de l’alimentation (FSAA), Université Laval, 2425 Rue de l’Agriculture, Québec City, Quebec G1V 0A6, Canada.
Département de médecine, Faculté de Médecine, Université Laval, 1050 Av. de la Médecine, Québec City, Quebec G1V 0A6, Canada.
Joint International Unit between the National Research Council (CNR) of Italy and Université Laval on Chemical and Biomolecular Research on the Microbiome and its Impact on Metabolic Health and Nutrition (UMI-MicroMeNu), Institute of Biomolecular Chemistry, CNR, Pozzuoli, Italy.
Search for other papers by V. Di Marzo in
Current site
Google Scholar
PubMed
Centre de recherche de l’Institut universitaire de cardiologie et de pneumologie de Québec (IUCPQ), 2725 Ch Ste-Foy, Québec City, Quebec G1V 4G5, Canada.
Canada Research Excellence Chair in the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Université Laval, Québec, Canada.
École de nutrition, Faculté des sciences de l’agriculture et de l’alimentation (FSAA), Université Laval, 2425 Rue de l’Agriculture, Québec City, Quebec G1V 0A6, Canada.
Search for other papers by A. Veilleux in
Current site
Google Scholar
PubMed
Probiotics represent a promising tool to improve metabolic health, including lipid profiles and cholesterol levels. Modulation of the gut microbiome and the endocannabinoidome – two interrelated systems involved in several metabolic processes influenced by probiotics – has been proposed as a potential mechanism of action. This study establishes the impact of probiotics on metabolic health, gut microbiota composition and endocannabinoidome mediators in an animal model of hypercholesterolaemia. Syrian hamsters were fed either a low-fat low-cholesterol or high-fat high-cholesterol (HFHC) diet to induce hypercholesterolaemia and gavaged for 6 weeks with either Lactobacillus acidophilus CL1285, Lactiplantibacillus plantarum CHOL-200 or a combination of the two. Globally, probiotic interventions ameliorated, at least partially, lipid metabolism in HFHC-fed hamsters. The interventions, especially those including L. acidophilus, modified the gut microbiota composition of the small intestine and caecum in ways suggesting reversal of HFHC-induced dysbiosis. Several associations were observed between changes in gut microbiota composition and endocannabinoidome mediators following probiotic interventions and both systems were also associated with improved metabolic health parameters. For instance, potential connexions between the Eubacteriaceae and Deferribacteraceae families, levels of 2‑palmitoylglycerol, 2‑oleoylglycerol, 2‑linoleoylglycerol or 2‑eicosapentaenoylglycerol and improved lipid profiles were found. Altogether, our results suggest a potential crosstalk between gut microbiota and the endocannabinoidome in driving metabolic benefits associated with probiotics, especially those including L. acidophilus, in an animal model of hypercholesterolaemia.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 863 | 204 | 33 |
| Full Text Views | 52 | 6 | 0 |
| PDF Views & Downloads | 71 | 15 | 0 |
